Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Role of race in severity and survival of those with cutaneous T-cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAlmeera Lateef

Discussion

Loading...

Member takes

Overview

Analysis reveals racial differences in bacteremia rates among cutaneous T-cell lymphoma patients, suggesting implications for treatment.

Key Points

  • To explore the influence of race on the severity and survival of patients with cutaneous T-cell lymphoma.
  • Identified patients with cutaneous cultures from a CTCL database at Emory University.
  • Compared rates of colonization and bacteremia between Black and White patients.
  • Employed statistical tests such as ANOVA, Chi-square, and Cox regression for analysis.
  • Among 213 patients, colonization rate was 23% with higher bacteremia in Black patients (p<.0008).
  • MSSA was more prevalent in women (OR=2.76; p<0.038).
  • Patients over 60 had lower likelihood of bacteremia but reduced survival rates when infected (p<0.015).

Cite This Study

Almeera Lateef (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236debdhttps://doi.org/10.1182/blood-2025-5428
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bacterial skin colonization and systemic antibiotic treatment in patients with cutaneous T‐cell lymphoma2025 · 1 citations
  2. 2Racial differences in therapies received by patients with cutaneous T cell lymphoma (CTCL): A single center retrospective cohort analysis.2024
  3. 3Persistent racial disparities in Sézary syndrome outcomes despite use of modern therapies: A single-center analysis2025
  4. 4Racial differences in survival and prognostic factors among patients with mycosis fungoides and Sézary syndrome: A systematic review and meta-analysis.2026
  5. 5Locational patterns and ecological catalysts of cutaneous T-cell lymphoma: Insights from a Louisiana medical center (2019–2024)2025